Deprescribing trials need a rationale-first framework before choosing trial design
The Lancet Healthy Longevity · 2026-08 · 7 (8) · 100892
DOI: 10.1016/j.lanhl.2026.100892 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Lancet Healthy Longevity, 2026-08. Verfasst von Lorenz Roger Van der Linden. Beteiligte Einrichtung: Hospital Pharmacy Department, University Hospitals Leuven, Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 300…. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In their Comment, published in The Lancet Healthy Longevity, Catherine S Hwang and colleagues provide a rigorous argument for the use of non-inferiority designs in medication deprescribing research.1 Their formulation of the null hypothesis, implications of attrition bias, and dual-analysis requirement for non-inferiority inference are important methodological contributions. Non-inferiority designs shift the burden of proof appropriately when treatment continuation is the default. Three further considerations merit attention.
Autor:innen und Institutionen
- Hospital Pharmacy Department, University Hospitals Leuven, Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium. Electronic address: lorenz.vanderlinden@uzleuven.be.
Zitieren
APA
Van der Linden, L. R. (2026). Deprescribing trials need a rationale-first framework before choosing trial design. The Lancet Healthy Longevity, 7(8), 100892. https://doi.org/10.1016/j.lanhl.2026.100892
Vancouver
Van der Linden LR. Deprescribing trials need a rationale-first framework before choosing trial design. The Lancet Healthy Longevity. 2026;7(8):100892. doi:10.1016/j.lanhl.2026.100892
BibTeX
@article{VanderLinden2026,
author = {Van der Linden, Lorenz Roger},
title = {Deprescribing trials need a rationale-first framework before choosing trial design},
journal = {The Lancet Healthy Longevity},
year = {2026},
volume = {7},
number = {8},
pages = {100892},
doi = {10.1016/j.lanhl.2026.100892}
}
EUVIMED